Stage III Renal Pelvis and Ureter Cancer AJCC v8

3 clinical trials · Condition

Record	Firm	Date
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study (NCT05092958)	National Cancer Institute (NCI)	2022-06-03
Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study (NCT04398368)	Mayo Clinic	2020-06-05
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors (NCT02496208)	National Cancer Institute (NCI)	2015-07-22

Every clearance here is in the API, with alerts when new ones post.